We are live on ! Find out more
Truist Financial

Truist Financial Portfolio holdings

AUM $83.7B
1-Year Est. Return 27.22%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
+27.22%
3 Year Est. Return
+78.71%
5 Year Est. Return
+88.14%
10 Year Est. Return
+397.7%
AUM
$63.9B
AUM Growth
+$103M
Cap. Flow
+$97.3M
Cap. Flow %
0.15%
Top 10 Hldgs %
25.8%
Holding
2,669
New
171
Increased
1,077
Reduced
1,173
Closed
160
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FYC icon
2176
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.4B
$279K ﹤0.01%
3,607
+64
+2% +$5.03K
DUSA icon
2177
Davis Select US Equity ETF
DUSA
$1.28B
$279K ﹤0.01%
6,621
+1,053
+19% +$45.3K
BGC icon
2178
BGC Group
BGC
$4.89B
$278K ﹤0.01%
30,652
-22,680
-43% -$218K
FUL icon
2179
H.B. Fuller
FUL
$3.28B
$276K ﹤0.01%
4,089
-447
-10% -$33.6K
YELP icon
2180
Yelp
YELP
$1.41B
$276K ﹤0.01%
+7,124
New +$260K
HLMN icon
2181
Hillman Solutions
HLMN
$1.79B
$275K ﹤0.01%
28,264
-808
-3% -$8.64K
SCMB icon
2182
Schwab Municipal Bond ETF
SCMB
$3.98B
$275K ﹤0.01%
+5,275
New +$137K
NBOS icon
2183
Neuberger Option Strategy ETF
NBOS
$527M
$272K ﹤0.01%
+10,306
New +$273K
EIS icon
2184
iShares MSCI Israel ETF
EIS
$903M
$271K ﹤0.01%
3,522
-50
-1% -$3.57K
IFN
2185
Aberdeen India Fund
IFN
$504M
$271K ﹤0.01%
17,184
ADX icon
2186
Adams Diversified Equity Fund
ADX
$3.2B
$269K ﹤0.01%
13,333
+116
+0.9% +$2.48K
NARI
2187
DELISTED
Inari Medical, Inc. Common Stock
NARI
$269K ﹤0.01%
5,270
-338
-6% -$16.6K
WSFS icon
2188
WSFS Financial
WSFS
$4.15B
$269K ﹤0.01%
5,056
-100
-2% -$5.44K
VRTS icon
2189
Virtus Investment Partners
VRTS
$1.1B
$269K ﹤0.01%
1,217
+13
+1% +$2.96K
QLTY icon
2190
GMO US Quality ETF
QLTY
$5.07B
$268K ﹤0.01%
8,397
-1,549
-16% -$50.3K
VSMV icon
2191
VictoryShares US Multi-Factor Minimum Volatility ETF
VSMV
$158M
$268K ﹤0.01%
5,589
-760
-12% -$37.3K
ONTO icon
2192
Onto Innovation
ONTO
$15.3B
$268K ﹤0.01%
1,605
+421
+36% +$76.9K
LGND icon
2193
Ligand Pharmaceuticals
LGND
$6.36B
$267K ﹤0.01%
2,496
-149
-6% -$16.8K
RECS icon
2194
Columbia Research Enhanced Core ETF
RECS
$6.05B
$267K ﹤0.01%
7,721
+148
+2% +$5.19K
THQ
2195
abrdn Healthcare Opportunities Fund
THQ
$796M
$267K ﹤0.01%
14,151
-83
-0.6% -$1.72K
Z icon
2196
PUT
Zillow
Z
$7.56B
$267K ﹤0.01%
3,600
-900
-20% -$64.3K
GBF icon
2197
iShares Government/Credit Bond ETF
GBF
$128M
$266K ﹤0.01%
2,605
+212
+9% +$22K
IHDG icon
2198
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.25B
$266K ﹤0.01%
6,116
-76
-1% -$3.39K
CWK icon
2199
Cushman & Wakefield Ltd
CWK
$3.25B
$264K ﹤0.01%
20,189
-1,202
-6% -$16.7K
CSW
2200
CSW Industrials
CSW
$5.71B
$264K ﹤0.01%
747
+11
+1% +$4.28K

Similar funds

Truist Financial's Q4 2024 Portfolio in Review

As of Q4 2024, Truist Financial held 2,669 positions worth $63.9B, up 0.16% from $63.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Truist Financial's Q4 2024 filing shows 171 new, 1,077 increased, 1,173 reduced and 160 closed positions. Its largest new stake was FT Vest Laddered Moderate Buffer ETF: 366,873 shares worth $8.76M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $204M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Truist Financial's largest Q4 2024 buy was FT Vest Laddered Moderate Buffer ETF: 366,873 shares worth $8.76M.
  • Truist Financial added most to iShares Core MSCI Emerging Markets ETF in Q4 2024, an estimated $139M increase.
  • Truist Financial's biggest Q4 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $204M.
  • Truist Financial fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $13.7M.
  • Truist Financial's ten largest holdings make up 26% of its $63.9B portfolio in Q4 2024.
  • Truist Financial opened 171 new positions and closed 160 in Q4 2024.
  • Truist Financial's portfolio value rose 0.16% quarter-over-quarter to $63.9B.

Based on Truist Financial's 13F filing for Q4 2024, filed 31 Jan 2025.